Rapid emergence of emm84 among invasive Streptococcus pyogenes infections in Finland

Journal of Clinical Microbiology

Volumn 47, Issue 2, 2009, Pages 477-480

  Siljander, Tuula ^a   Lyytikäinen, Outi ^a   Vähäkuopus, Susanna ^a   Säilä, Petrus ^a,b   Jalava, Jari ^a   Vuopio Varkila, Jaana ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; DISEASE SURVEILLANCE; EMM84 GENE; FINLAND; GENOTYPE; GROUP A STREPTOCOCCAL INFECTION; HUMAN; INCIDENCE; PREVALENCE; PRIORITY JOURNAL; STREPTOCOCCUS PYOGENES; CLASSIFICATION; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MORTALITY; STREPTOCOCCUS INFECTION;

STREPTOCOCCUS PYOGENES;

BACTERIAL ANTIGEN; CARRIER PROTEIN; OUTER MEMBRANE PROTEIN; STREPTOCOCCAL M PROTEIN;

ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; FINLAND; HUMANS; INCIDENCE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 60849098159     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01663-08     Document Type: Article

References (34)

1. Carapetis, J., R. Robins-Browne, D. Martin, T. Shelby-James, and G. Hogg. 1995. Increasing severity of invasive group A streptococcal disease in Australia: clinical and molecular epidemiological features and identification of a new virulent M-nontypeable clone. Clin. Infect. Dis. 21:1220-1227.
2. CLSI. 2007. Performance standard for antimicrobial susceptibility testing. Seventeenth informational supplement M100-S17, vol 24, no. 1. CLSI, Wayne, PA.
3. Cohen-Poradosu, R., and D. L. Kasper. 2007. Group A streptococcus epidemiology and vaccine implications. Clin. Infect. Dis. 45:863-865.
4. Darenberg, J., B. Luca-Harari, A. Jasir, A. Sandgren, H. Pettersson, C. Schalen, M. Norgren, V. Romanus, A. Norrby-Teglund, and B. H. Normark. 2007. Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin. Infect. Dis. 45:450-458.
5. Efstratiou, A. 2000. Group A streptococci in the 1990s. J. Antimicrob. Chemother. 45(Suppl.):3-12.
6. Ekelund, K., J. Darenberg, A. Norrby-Teglund, S. Hoffmann, D. Bang, P. Skinhoj, and H. B. Konradsen. 2005. Variations in emm type among group A streptococcal isolates causing invasive or noninvasive infections in a nationwide study. J. Clin. Microbiol. 43:3101-3109.
7. Eriksson, B. K., J. Andersson, S. E. Holm, and M. Norgren. 1999. Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome. J. Infect. Dis. 180:410-418.
8. Hoe, N. P., P. Kordari, R. Cole, M. Liu, T. Palzkill, W. Huang, D. McLellan, G. J. Adams, M. Hu, J. Vuopio-Varkila, T. R. Cate, M. E. Pichichero, K. M. Edwards, J. Eskola, D. E. Low, and J. M. Musser. 2000. Human immune response to streptococcal inhibitor of complement, a serotype M1 group A Streptococcus extracellular protein involved in epidemics. J. Infect. Dis. 182:1425-1436.
9. Johnson, D. R., E. L. Kaplan, A. VanGheem, R. R. Facklam, and B. Beall. 2006. Characterization of group A streptococci (Streptococcus pyogenes): correlation of M-protein and emm-gene type with T-protein agglutination pattern and serum opacity factor. J. Med. Microbiol. 55:157-164.
10. Kotloff, K. L., M. Corretti, K. Palmer, J. D. Campbell, M. A. Reddish, M. C. Hu, S. S. Wasserman, and J. B. Dale. 2004. Safety and immunogenicity of a recombinant multivalent group A streptococcal vaccine in healthy adults: phase 1 trial. JAMA 292:709-715.
11. Krucso, B., M. Gacs, B. Libisch, Z. V. Hunyadi, K. Molnar, M. Fuzi, and J. Paszti. 2007. Molecular characterisation of invasive Streptococcus pyogenes isolates from Hungary obtained in 2004 and 2005. Eur. J. Clin. Microbiol. Infect. Dis. 26:807-811.
12. Lamagni, T., A. Efstratiou, J. Vuopio-Varkila, A. Jasir, and C. Schalen. 2005. The epidemiology of severe Streptococcus pyogenes associated disease in Europe. Euro Surveill. 10:179-184.
13. Lamagni, T. L., S. Neal, C. Keshishian, N. Alhaddad, R. George, G. Duckworth, J. Vuopio-Varkila, and A. Efstratiou. 2008. Severe Streptococcus pyogenes infections, United Kingdom, 2003-2004. Emerg. Infect. Dis. 14:202-209.
14. Luca-Harari, B., K. Ekelund, M. van der Linden, M. Staum-Kaltoft, A. M. Hammerum, and A. Jasir. 2008. Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004. J. Clin. Microbiol. 46:79-86.
15. Maripuu, L., A. Eriksson, and M. Norgren. 2008. Superantigen gene profile diversity among clinical group A streptococcal isolates. FEMS Immunol. Med. Microbiol. 54:236-244.
16. McNeil, S. A., S. A. Halperin, J. M. Langley, B. Smith, A. Warren, G. P. Sharratt, D. M. Baxendale, M. A. Reddish, M. C. Hu, S. D. Stroop, J. Linden, L. F. Fries, P. E. Vink, and J. B. Dale. 2005. Safety and immunogenicity of 26-valent group A Streptococcus vaccine in healthy adult volunteers. Clin. Infect. Dis. 41:1114-1122.
17. Moody, M. D., J. Padula, D. Lizana, and C. T. Hall. 1965. Epidemiologic characterization of group A streptococci by T-agglutination and M-precipitation tests in the public health laboratory. Health Lab. Sci. 2:149-162.
18. Musser, J. M., A. R. Hauser, M. H. Kim, P. M. Schlievert, K. Nelson, and R. K. Selander. 1991. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc. Natl. Acad. Sci. USA 88:2668-2672.
19. O'Brien, K. L., B. Beall, N. L. Barrett, P. R. Cieslak, A. Reingold, M. M. Farley, R. Danila, E. R. Zell, R. Facklam, B. Schwartz, and A. Schuchat. 2002. Epidemiology of invasive group A streptococcus disease in the United States, 1995-1999. Clin. Infect. Dis. 35:268-276.
20. O'Loughlin, R. E., A. Roberson, P. R. Cieslak, R. Lynfield, K. Gershman, A. Craig, B. A. Albanese, M. M. Farley, N. L. Barrett, N. L. Spina, B. Beall, L. H. Harrison, A. Reingold, and C. Van Beneden. 2007. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin. Infect. Dis. 45:853-862.
21. Richter, S. S., K. P. Heilmann, S. E. Beekmann, N. J. Miller, A. L. Miller, C. L. Rice, C. D. Doern, S. D. Reid, and G. V. Doern. 2005. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003. Clin. Infect. Dis. 41:599-608.
22. Schmitz, F. J., A. Beyer, E. Charpentier, B. H. Normark, M. Schade, A. C. Fluit, D. Hafner, and R. Novak. 2003. Toxin-gene profile heterogeneity among endemic invasive European group A streptococcal isolates. J. Infect. Dis. 188:1578-1586.
23. Siljander, T., M. Karppelin, S. Vahakuopus, J. Syrjanen, M. Toropainen, J. Kere, R. Vuento, T. Jussila, and J. Vuopio-Varkila. 2008. Acute bacterial, nonnecrotizing cellulitis in Finland: microbiological findings. Clin. Infect. Dis. 46:855-861.
24. Siljander, T., O. Lyytikäinen, P. Säilä, S. Vähäkuopus, J. Iivonen, and J. Vuopio-Varkila. 2007. Invasive group A streptococcal infections, Finland, 2004-2006: outcome and emm types, p. 234. Abstr. Eur. Sci. Conf. Appl. Infect. Dis. Epidemiol., 20 October 2007, Stockholm, Sweden.
25. Siljander, T., O. Lyytikäinen, S. Vähäkuopus, J. Iivonen, and J. Vuopio-Varkila. 2008. Rapid changes in invasive group A streptococcal infections and emm types, Finland, 2005-2007, p. 37. Abstr. XVII Lancefield Int. Symp. Streptococci Streptococcal Dis., 23 June 2008, Porto Heli, Greece.
26. Siljander, T., M. Toropainen, A. Muotiala, N. P. Hoe, J. M. Musser, and J. Vuopio-Varkila. 2006. emm typing of invasive T28 group A streptococci, 1995-2004, Finland. J. Med. Microbiol. 55:1701-1706.
27. Stanley, J., D. Linton, M. Desai, A. Efstratiou, and R. George. 1995. Molecular subtyping of prevalent M serotypes of Streptococcus pyogenes causing invasive disease. J. Clin. Microbiol. 33:2850-2855.
28. Stevens, D. L., M. H. Tanner, J. Winship, R. Swarts, K. M. Ries, P. M. Schlievert, and E. Kaplan. 1989. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N. Engl. J. Med. 321:1-7.
29. Sumby, P., S. F. Porcella, A. G. Madrigal, K. D. Barbian, K. Virtaneva, S. M. Ricklefs, D. E. Sturdevant, M. R. Graham, J. Vuopio-Varkila, N. P. Hoe, and J. M. Musser. 2005. Evolutionary origin and emergence of a highly successful clone of serotype M1 group A Streptococcus involved multiple horizontal gene transfer events. J. Infect. Dis. 192:771-782.
30. Szczypa, K., E. Sadowy, R. Izdebski, L. Strakova, and W. Hryniewicz. 2006. Group A streptococci from invasive-disease episodes in Poland are remarkably divergent at the molecular level. J. Clin. Microbiol. 44:3975-3979.
31. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
32. Tewodros, W., and G. Kronvall. 2005. M protein gene (emm type) analysis of group A beta-hemolytic streptococci from Ethiopia reveals unique patterns. J. Clin. Microbiol. 43:4369-4376.
33. Tyrrell, G. J., M. Lovgren, B. Kress, and K. Grimsrud. 2005. Invasive group A streptococcal disease in Alberta, Canada (2000 to 2002). J. Clin. Microbiol. 43:1678-1683.
34. Zachariadou, L., J. Papaparaskevas, I. Paraskakis, A. Efstratiou, A. Pangalis, N. J. Legakis, and P. T. Tassios. 2003. Predominance of two M-types among erythromycin-resistant group A streptococci from Greek children. Clin. Microbiol. Infect. 9:310-314.